Drug Profile
Tolterodine/tamsulosin - Sun Pharmaceutical Industries
Alternative Names: Roliflo OD; Tamsulosin/tolterodineLatest Information Update: 08 Feb 2019
Price :
$50
*
At a glance
- Originator Ranbaxy Laboratories
- Developer Sun Pharmaceutical Industries
- Class Amines; Antispasmodics; Benzene derivatives; Benzhydryl compounds; Cresols; Ethers; Small molecules; Sulfonamides
- Mechanism of Action Alpha-1a adrenergic receptor antagonists; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Overactive bladder; Urinary bladder neck obstruction
Most Recent Events
- 08 Feb 2019 Chemical structure information added
- 25 Mar 2015 Ranbaxy Laboratories has been acquired by Sun Pharmaceutical Industries
- 20 Oct 2008 Ranbaxy Laboratories has been acquired by Daiichi Sankyo Company